These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Cutolo M; Ruaro B; Montagna P; Brizzolara R; Stratta E; Trombetta AC; Scabini S; Tavilla PP; Parodi A; Corallo C; Giordano N; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S Arthritis Res Ther; 2018 May; 20(1):77. PubMed ID: 29720235 [TBL] [Abstract][Full Text] [Related]
23. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis. Leask A Keio J Med; 2004 Jun; 53(2):74-7. PubMed ID: 15247510 [TBL] [Abstract][Full Text] [Related]
25. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. Holmes A; Abraham DJ; Sa S; Shiwen X; Black CM; Leask A J Biol Chem; 2001 Apr; 276(14):10594-601. PubMed ID: 11152469 [TBL] [Abstract][Full Text] [Related]
26. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. Sato M; Shegogue D; Gore EA; Smith EA; McDermott PJ; Trojanowska M J Invest Dermatol; 2002 Apr; 118(4):704-11. PubMed ID: 11918720 [TBL] [Abstract][Full Text] [Related]
27. TGF beta--a role in systemic sclerosis? Cotton SA; Herrick AL; Jayson MI; Freemont AJ J Pathol; 1998 Jan; 184(1):4-6. PubMed ID: 9582519 [TBL] [Abstract][Full Text] [Related]
28. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma. Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317 [TBL] [Abstract][Full Text] [Related]
29. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts. Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442 [TBL] [Abstract][Full Text] [Related]
31. Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis. Chujo S; Shirasaki F; Kondo-Miyazaki M; Ikawa Y; Takehara K J Cell Physiol; 2009 Jul; 220(1):189-95. PubMed ID: 19277979 [TBL] [Abstract][Full Text] [Related]
32. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy. Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446 [TBL] [Abstract][Full Text] [Related]
33. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis. Yu CC; Tsai CH; Hsu HI; Chang YC PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075 [TBL] [Abstract][Full Text] [Related]
34. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition. Ghosh AK; Bradham WS; Gleaves LA; De Taeye B; Murphy SB; Covington JW; Vaughan DE Circulation; 2010 Sep; 122(12):1200-9. PubMed ID: 20823384 [TBL] [Abstract][Full Text] [Related]
35. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis. Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895 [TBL] [Abstract][Full Text] [Related]
37. Vascular alterations upon activation of TGFbeta signaling in fibroblasts--implications for systemic sclerosis. Horn A; Distler JH Arthritis Res Ther; 2010; 12(3):125. PubMed ID: 20602813 [TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis. Ide M; Jinnin M; Tomizawa Y; Wang Z; Kajihara I; Fukushima S; Hashizume Y; Asano Y; Ihn H Exp Dermatol; 2017 Nov; 26(11):1139-1143. PubMed ID: 28418584 [TBL] [Abstract][Full Text] [Related]
39. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts. Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645 [TBL] [Abstract][Full Text] [Related]
40. Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis. Wu M; Pedroza M; Lafyatis R; George AT; Mayes MD; Assassi S; Tan FK; Brenner MB; Agarwal SK Arthritis Rheumatol; 2014 Apr; 66(4):1010-21. PubMed ID: 24757152 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]